Page last updated: 2024-11-06

5-pregnene-3,20-diol

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

5-Pregnene-3,20-diol, also known as pregnenolone, is a steroid hormone precursor that plays a crucial role in the biosynthesis of other steroid hormones, including progesterone, cortisol, and testosterone. It is synthesized in the adrenal glands, ovaries, and testes. Pregnenolone is involved in various physiological processes, such as neuroprotection, memory formation, and stress response. It has also been investigated for its potential therapeutic applications in conditions like Alzheimer's disease and depression. Research on pregnenolone focuses on its role in steroid hormone synthesis, its potential neuroprotective effects, and its therapeutic implications in various neurological and psychological disorders.'

5-pregnene-3,20-diol: RN given refers to (3 beta,20 alpha)-isomer [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID94194
CHEMBL ID4174453
CHEBI ID166781
SCHEMBL ID2516395
MeSH IDM0053404

Synonyms (32)

Synonym
(3s,8s,9s,10r,13s,14s,17s)-17-[(1s)-1-hydroxyethyl]-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1h-cyclopenta[a]phenanthren-3-ol
901-56-4
pregn-5-ene-3beta,20alpha-diol
CHEBI:166781
20beta-dihydropregnenolone
pregn-5-en-3beta,20s-diol
LMST02030205
delta5-pregnenediol
20alpha-dihydropregnenolone
3z565yjo1o ,
pregn-5-ene-3,20-diol, (3beta,20s)
5-pregnene-3beta,20alpha-diol
5-pregnene-3,20-diol
unii-3z565yjo1o
(3.beta.,20s)-pregn-5-ene-3,20-diol
.delta.5-pregnene-3.beta.,20.alpha.-diol
20.alpha.-hydroxypregnenolone
pregnenediol
pregn-5-ene-3.beta.,20.alpha.-diol
3.beta.,20.alpha.-dihydroxypregn-5-ene
.delta.5-pregnenediol
20.alpha.-dihydropregnenolone
pregn-5-ene-3,20-diol, (3.beta.,20s)-
SCHEMBL2516395
5-pregnen-3.beta.,20.alpha.-diol
QAAQQTDJEXMIMF-YZXCLFAISA-N
.delta.-5-pregnen-3.beta.,20.alpha.-diol
pregn-5-ene-3,20-diol
Q27258244
DTXSID801009158
CHEMBL4174453
20alpha-dihydro pregnenolone
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
corticosteroid hormoneAny of a class of steroid hormones that are produced in the adrenal cortex.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Pathways (1)

PathwayProteinsCompounds
Steroid hormone precursor biosynthesis015

Bioassays (4)

Assay IDTitleYearJournalArticle
AID1502695Inhibition of DHCR24-mediated cholesterol biosynthesis in human HL60 cells assessed as inhibition of 2-[13C]acetate incorporation into newly synthesized cholesterol after 24 hrs GC/MS analysis2017European journal of medicinal chemistry, Nov-10, Volume: 140New chemotype of selective and potent inhibitors of human delta 24-dehydrocholesterol reductase.
AID1502681Cytotoxicity in human HL60 cells by MTT assay2017European journal of medicinal chemistry, Nov-10, Volume: 140New chemotype of selective and potent inhibitors of human delta 24-dehydrocholesterol reductase.
AID1502689Induction of sterol accumulation in human HL60 cells at 1 uM incubated for 24 hrs by GC-MS analysis2017European journal of medicinal chemistry, Nov-10, Volume: 140New chemotype of selective and potent inhibitors of human delta 24-dehydrocholesterol reductase.
AID1502690Induction of sterol accumulation in human HL60 cells at 50 uM incubated for 24 hrs by GC-MS analysis2017European journal of medicinal chemistry, Nov-10, Volume: 140New chemotype of selective and potent inhibitors of human delta 24-dehydrocholesterol reductase.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (20)

TimeframeStudies, This Drug (%)All Drugs %
pre-199015 (75.00)18.7374
1990's2 (10.00)18.2507
2000's1 (5.00)29.6817
2010's2 (10.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.44

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index11.44 (24.57)
Research Supply Index3.09 (2.92)
Research Growth Index4.53 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (11.44)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (4.76%)6.00%
Case Studies1 (4.76%)4.05%
Observational0 (0.00%)0.25%
Other19 (90.48%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]